257 related articles for article (PubMed ID: 16672910)
1. Metabolomic study of cisplatin-induced nephrotoxicity.
Portilla D; Li S; Nagothu KK; Megyesi J; Kaissling B; Schnackenberg L; Safirstein RL; Beger RD
Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
[TBL] [Abstract][Full Text] [Related]
2. Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu KK; Bhatt R; Kaushal GP; Portilla D
Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
Li S; Gokden N; Okusa MD; Bhatt R; Portilla D
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F469-80. PubMed ID: 15814532
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
Portilla D; Schnackenberg L; Beger RD
Semin Nephrol; 2007 Nov; 27(6):609-20. PubMed ID: 18061843
[TBL] [Abstract][Full Text] [Related]
5. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
[TBL] [Abstract][Full Text] [Related]
6. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
[TBL] [Abstract][Full Text] [Related]
7. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.
Negishi K; Noiri E; Sugaya T; Li S; Megyesi J; Nagothu K; Portilla D
Kidney Int; 2007 Aug; 72(3):348-58. PubMed ID: 17495861
[TBL] [Abstract][Full Text] [Related]
8. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure.
Portilla D; Dai G; McClure T; Bates L; Kurten R; Megyesi J; Price P; Li S
Kidney Int; 2002 Oct; 62(4):1208-18. PubMed ID: 12234291
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.
Li S; Nagothu KK; Desai V; Lee T; Branham W; Moland C; Megyesi JK; Crew MD; Portilla D
Kidney Int; 2009 Nov; 76(10):1049-62. PubMed ID: 19710628
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice.
Jesse CR; Bortolatto CF; Wilhelm EA; Roman SS; Prigol M; Nogueira CW
J Appl Toxicol; 2014 Jan; 34(1):25-32. PubMed ID: 22987311
[TBL] [Abstract][Full Text] [Related]
11. Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants.
Xu EY; Perlina A; Vu H; Troth SP; Brennan RJ; Aslamkhan AG; Xu Q
Chem Res Toxicol; 2008 Aug; 21(8):1548-61. PubMed ID: 18656965
[TBL] [Abstract][Full Text] [Related]
12. Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.
Li S; Nagothu K; Ranganathan G; Ali SM; Shank B; Gokden N; Ayyadevara S; Megyesi J; Olivecrona G; Chugh SS; Kersten S; Portilla D
Am J Physiol Renal Physiol; 2012 Aug; 303(3):F437-48. PubMed ID: 22622461
[TBL] [Abstract][Full Text] [Related]
13. Potential utility of PPARalpha activation in the prevention of ischemic and drug-induced acute renal damage.
Lopez-Hernandez FJ; Lopez-Novoa JM
Kidney Int; 2009 Nov; 76(10):1022-4. PubMed ID: 19876055
[TBL] [Abstract][Full Text] [Related]
14. Urinary metabolic profiling of cisplatin nephrotoxicity and nephroprotective effects of Orthosiphon stamineus leaves elucidated by
Pariyani R; Ismail IS; Azam A; Khatib A; Abas F; Shaari K; Hamza H
J Pharm Biomed Anal; 2017 Feb; 135():20-30. PubMed ID: 27987392
[TBL] [Abstract][Full Text] [Related]
15. The pathological role of Bax in cisplatin nephrotoxicity.
Wei Q; Dong G; Franklin J; Dong Z
Kidney Int; 2007 Jul; 72(1):53-62. PubMed ID: 17410096
[TBL] [Abstract][Full Text] [Related]
16. Protective Effect of Panduratin A on Cisplatin-Induced Apoptosis of Human Renal Proximal Tubular Cells and Acute Kidney Injury in Mice.
Thongnuanjan P; Soodvilai S; Fongsupa S; Chabang N; Vivithanaporn P; Tuchinda P; Soodvilai S
Biol Pharm Bull; 2021; 44(6):830-837. PubMed ID: 34078815
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin against cisplatin induced acute renal injury in rats: a biochemical and histoarchitectural evaluation.
Sahu BD; Kuncha M; Putcha UK; Sistla R
Exp Toxicol Pathol; 2013 Sep; 65(6):933-40. PubMed ID: 23395153
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin nephrotoxicity and protection by silibinin.
Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
[TBL] [Abstract][Full Text] [Related]
19. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice.
Ueki M; Ueno M; Morishita J; Maekawa N
J Biosci Bioeng; 2013 May; 115(5):547-51. PubMed ID: 23245727
[TBL] [Abstract][Full Text] [Related]
20. Effect of glycine on cisplatin nephrotoxicity and heat-shock protein 70 expression in the rat kidney.
Musio F; Carome MA; Bohen EM; Sabnis S; Yuan CM
Ren Fail; 1997 Jan; 19(1):33-46. PubMed ID: 9044450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
